Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 2 of 2 for “"Bendamustine"”.

  1. Actions of Pi3K-Delta Inhibitor, Idelalisib, and Its Combination With Bendamustine In Chronic Lymphocytic Leukemia

    … for DNA damage and repair response.</p> <p>Bendamustine is a FDA approved alkylating agent for CLL therapy. We hypothesized that idelalisib-mediated decline in Mcl-1and bendamustine-induced DNA damage will sensitize B-CLL cells and this mechanism-based combination will lead to a synergistic …

    uthsc Repository record for Actions of Pi3K-Delta Inhibitor, Idelalisib, and Its Combination With Bendamustine In Chronic Lymphocytic Leukemia (opens in a new tab)

  2. Pim Kinase Inhibition: Single Agent and Combination Approaches In B-Cell Lymphoma

    … a combination strategy using SGI-1776 with bendamustine, an FDA-approved DNA-damaging alkylating agent for treating non-Hodgkin’s lymphoma. We hypothesized this combination will enhance SGI-1776-induced transcription and translation inhibition, while promoting bendamustine-triggered DNA …

    uthsc Repository record for Pim Kinase Inhibition: Single Agent and Combination Approaches In B-Cell Lymphoma (opens in a new tab)